US6338963B1
(en)
|
1994-07-25 |
2002-01-15 |
Neotherapeutics, Inc. |
Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
|
AU744902B2
(en)
*
|
1997-09-11 |
2002-03-07 |
Oxigene, Inc. |
Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
|
US6303617B1
(en)
|
1998-05-04 |
2001-10-16 |
Neotherapeutics, Inc. |
Serotonin-like 9-substituted hypoxanthine and methods of use
|
DE69904257T2
(de)
*
|
1999-01-20 |
2003-04-17 |
N.V. Nutricia, Zoetermeer |
Säuglingsnährpräparat
|
US6426362B1
(en)
*
|
1999-10-08 |
2002-07-30 |
Galileo Laboratories, Inc. |
Formulations of tocopherols and methods of making and using them
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
US6288069B1
(en)
|
1999-11-16 |
2001-09-11 |
Neotherapeutics, Inc. |
Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
|
US6407237B1
(en)
|
2001-02-21 |
2002-06-18 |
Neotherapeutics, Inc. |
Crystal forms of 9-substituted hypoxanthine derivatives
|
US6849735B1
(en)
*
|
2000-06-23 |
2005-02-01 |
Merck Eprova Ag |
Methods of synthesis for 9-substituted hypoxanthine derivatives
|
ES2385931T3
(es)
|
2000-07-07 |
2012-08-03 |
Spectrum Pharmaceuticals, Inc. |
MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
|
US7034054B2
(en)
*
|
2000-12-15 |
2006-04-25 |
Galileo Pharmaceuticals, Inc. |
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
US6759427B2
(en)
|
2001-04-20 |
2004-07-06 |
Spectrum Pharmaceuticals, Inc. |
Synthesis and methods of use of tetrahydroindolone analogues and derivatives
|
WO2003006613A2
(en)
*
|
2001-07-10 |
2003-01-23 |
Massachusetts Institute Of Technology |
Methods for ex vivo propagation of somatic stem cells
|
US7645610B2
(en)
*
|
2002-02-15 |
2010-01-12 |
Massachusetts Institute Of Technology |
Hepatocyte precursor cell lines
|
EP1352910A1
(en)
*
|
2002-04-10 |
2003-10-15 |
Grünenthal GmbH |
New analogs of nitrobenzylthioinosine
|
WO2003099297A1
(en)
*
|
2002-05-21 |
2003-12-04 |
Abbott Laboratories |
Treatment of mucositis
|
US20050026874A1
(en)
*
|
2002-07-29 |
2005-02-03 |
Lockwood Samuel Fournier |
Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease
|
EP1532108B1
(en)
*
|
2002-07-29 |
2016-06-29 |
Cardax Pharma, Inc. |
Astaxanthin esters for the inhibition and amelioration of disease
|
US20050143475A1
(en)
*
|
2002-07-29 |
2005-06-30 |
Lockwood Samuel F. |
Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
|
US7375133B2
(en)
*
|
2002-07-29 |
2008-05-20 |
Cardax Pharmaceuticals, Inc. |
Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
|
US20050009788A1
(en)
*
|
2002-07-29 |
2005-01-13 |
Lockwood Samuel Fournier |
Carotenoid ester analogs or derivatives for controlling connexin 43 expression
|
US7320997B2
(en)
*
|
2002-07-29 |
2008-01-22 |
Cardax Pharmaceuticals, Inc. |
Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
|
US20050049248A1
(en)
*
|
2002-07-29 |
2005-03-03 |
Lockwood Samuel Fournier |
Carotenoid ether analogs or derivatives for controlling C-reactive protein levels
|
US7521584B2
(en)
*
|
2002-07-29 |
2009-04-21 |
Cardax Pharmaceuticals, Inc. |
Carotenoid analogs or derivatives for the inhibition and amelioration of disease
|
US20050059659A1
(en)
*
|
2002-07-29 |
2005-03-17 |
Lockwood Samuel Fournier |
Carotenoid analogs or derivatives for controlling C-reactive protein levels
|
US20050148517A1
(en)
*
|
2002-07-29 |
2005-07-07 |
Lockwood Samuel F. |
Carotenoid ether analogs or derivatives for controlling connexin 43 expression
|
US20050059635A1
(en)
*
|
2002-07-29 |
2005-03-17 |
Lockwood Samuel Fournier |
Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
|
US7763649B2
(en)
*
|
2002-07-29 |
2010-07-27 |
Cardax Pharmaceuticals, Inc. |
Carotenoid analogs or derivatives for controlling connexin 43 expression
|
US20050004235A1
(en)
*
|
2002-07-29 |
2005-01-06 |
Lockwood Samuel Fournier |
Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease
|
US7723327B2
(en)
*
|
2002-07-29 |
2010-05-25 |
Cardax Pharmaceuticals, Inc. |
Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
|
US7345091B2
(en)
*
|
2002-07-29 |
2008-03-18 |
Cardax Pharmaceuticals, Inc. |
Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
|
WO2004044194A2
(en)
*
|
2002-11-07 |
2004-05-27 |
Rensselaer Polytechnic Institute |
Calmodulin independent activation of nitric oxide synthase by nadph analogs
|
JP2006517807A
(ja)
*
|
2002-12-30 |
2006-08-03 |
パーデュー・リサーチ・ファウンデーション |
中枢神経系の損傷の治療方法
|
US7470798B2
(en)
|
2003-09-19 |
2008-12-30 |
Edison Pharmaceuticals, Inc. |
7,8-bicycloalkyl-chroman derivatives
|
CA2564066A1
(en)
*
|
2004-04-14 |
2005-11-03 |
Hawaii Biotech, Inc. |
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
|
US20060058269A1
(en)
*
|
2004-04-14 |
2006-03-16 |
Lockwood Samuel F |
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
|
DK1758596T3
(da)
*
|
2004-05-26 |
2010-07-26 |
Inotek Pharmaceuticals Corp |
Purinderivater som adenosin-A1-receptoragonister og fremgangsmåder til anvendelse deraf
|
US7655465B2
(en)
*
|
2004-06-07 |
2010-02-02 |
Massachusetts Institute Of Technology |
Methods for ex vivo propagation of somatic hair follicle stem cells
|
US20050276762A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Tapas Das |
Topical compositions containing 5'-adenosine-diphosphate ribose
|
JP4724810B2
(ja)
*
|
2005-03-02 |
2011-07-13 |
財団法人ヒューマンサイエンス振興財団 |
ポリ(adp−リボース)代謝のバイオマーカーとしてのリボシルアデノシンおよびリボシルイノシン
|
US20060270590A1
(en)
|
2005-03-29 |
2006-11-30 |
Lockwood Samuel F |
Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof
|
DK1888059T3
(en)
*
|
2005-06-01 |
2015-03-30 |
Edison Pharmaceuticals Inc |
Redox-active therapeutic products for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers
|
WO2007002228A1
(en)
*
|
2005-06-23 |
2007-01-04 |
Massachusetts Institute Of Technology |
Methods for ex vivo propagation of adult hepatic stem cells
|
ITRM20050391A1
(it)
|
2005-07-22 |
2007-01-23 |
Giuliani Spa |
Composti analoghi della 6-tioguanosina trifosfato, loro uso in campo medico e procedimento per la loro preparazione.
|
EP1986636B1
(en)
|
2006-02-22 |
2013-04-24 |
Edison Pharmaceuticals, Inc. |
Phenol and 1,4-benzoquinone derivatives for use in the treatment of mitochondrial diseases
|
CN101453984A
(zh)
*
|
2006-03-31 |
2009-06-10 |
艾登欧比公司 |
使用腺苷和肌苷组合用于诊断和治疗的组合物、方法和试剂盒
|
EP3018122B1
(en)
|
2007-11-06 |
2018-10-10 |
BioElectron Technology Corporation |
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
|
EA023618B1
(ru)
*
|
2008-01-08 |
2016-06-30 |
Эдисон Фармасьютикалз, Инк. |
Производные (гет)арил-п-хинона для лечения митохондриальных болезней
|
JP5710277B2
(ja)
|
2008-03-05 |
2015-04-30 |
エジソン ファーマシューティカルズ, インコーポレイテッド |
酸化ストレス疾患の処置のための2−置換−p−キノン誘導体
|
WO2009158348A1
(en)
*
|
2008-06-25 |
2009-12-30 |
Edison Pharmaceuticals, Inc. |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
|
EP2344142B1
(en)
|
2008-09-10 |
2024-06-26 |
PTC Therapeutics, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
EP2362726B1
(en)
|
2008-10-14 |
2018-08-08 |
Bioelectron Technology Corporation |
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
CA2974482C
(en)
|
2008-10-28 |
2019-10-29 |
Bioelectron Technology Corporation |
High purity alpha tocotrienol quinone and processes for preparing same
|
BRPI1013376A8
(pt)
|
2009-04-28 |
2017-07-11 |
Edison Pharmaceuticals Inc |
Uso de quinonas de tocotrienol,preparação farmacêutica compreendendo as ditas quinonas e uso desta
|
EP2470168B1
(en)
*
|
2009-08-26 |
2018-01-31 |
BioElectron Technology Corporation |
Methods for the prevention and treatment of cerebral ischemia
|
SG10201502588UA
(en)
|
2010-01-11 |
2015-05-28 |
Inotek Pharmaceuticals Corp |
Combination, kit and method of reducing intraocular pressure
|
MX2012010724A
(es)
|
2010-03-26 |
2012-11-12 |
Inotek Pharmaceuticals Corp |
Metodo para reducir la presion intraocular en seres humanos empleando n6-ciclopentiladenosina (cpa), derivados de cpa o profarmacos de los mismos.
|
EP2601287B1
(en)
*
|
2010-08-05 |
2015-01-07 |
Amgen Inc. |
Dipeptides to enhance yield and viability from cell cultures
|
US9162957B2
(en)
|
2011-07-19 |
2015-10-20 |
Edison Pharmaceuticals, Inc. |
Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
|
US9278991B2
(en)
|
2012-01-26 |
2016-03-08 |
Inotek Pharmaceuticals Corporation |
Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
|
PL227045B1
(pl)
*
|
2012-09-14 |
2017-10-31 |
Blirt Spółka Akcyjna |
Płyn do przechowywania narządów w czasie zabiegów chirurgicznych, zwłaszcza transplantacji.
|
US9868711B2
(en)
|
2013-03-15 |
2018-01-16 |
Bioelectron Technology Corporation |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
US9296712B2
(en)
|
2013-03-15 |
2016-03-29 |
Edison Pharmaceuticals, Inc. |
Resorufin derivatives for treatment of oxidative stress disorders
|
US9670170B2
(en)
|
2013-03-15 |
2017-06-06 |
Bioelectron Technology Corporation |
Resorufin derivatives for treatment of oxidative stress disorders
|
CN105188714A
(zh)
|
2013-03-15 |
2015-12-23 |
伊诺泰克制药公司 |
眼用配制品
|
EP3233786B1
(en)
|
2014-12-16 |
2022-03-16 |
PTC Therapeutics, Inc. |
Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
|
US10745371B2
(en)
|
2015-12-16 |
2020-08-18 |
Ptc Therapeutics, Inc. |
Methods for enriching alpha-tocotrienol from mixed tocol compositions
|
US10703701B2
(en)
|
2015-12-17 |
2020-07-07 |
Ptc Therapeutics, Inc. |
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
|
JP2018083799A
(ja)
|
2016-11-15 |
2018-05-31 |
バイオエレクトロン テクノロジー コーポレイション |
2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩
|
ES2968957T3
(es)
|
2018-10-17 |
2024-05-14 |
Ptc Therapeutics Inc |
2,3,5-trimetil-6-nonilciclohexa-2,5-dieno-1,4-diona para la supresión y el tratamiento de alfa-sinucleinopatías, taupatías y otros trastornos
|
KR20240032997A
(ko)
|
2021-07-08 |
2024-03-12 |
피티씨 테라퓨틱스, 인크. |
2,3,5-트리메틸-6-노닐사이클로헥사-2,5-디엔-1,4-디온을 포함하는 약제학적 조성물
|